A Dietary Supplement Examined for Anti-ageing Effects

A 12-week Randomized Controlled Clinical Trial Evaluating the Efficacy of a Dietary Supplement in an Adult Population.

NCT06714162•Prenetics Global

View on ClinicalTrials.gov

Summary

dietary supplement for healthy ageing

Eligibility

Age

35 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Exclusion Criteria

•\-

Key Dates

Start Date

December 21, 2024

Primary Completion Date

February 27, 2025

Completion Date

April 1, 2025

Last Updated

December 3, 2024

Enrollment

ESTIMATED participants

Conditions

Ageing Signs

Interventions

Longevity pill

DIETARY_SUPPLEMENT

Contacts

John Ademola, PhD

CONTACT

9148862769 Jademola.sfinstitute@gmail.com

Anti-Ageing Health Supplement From Ginger Extracts

NCT06828783

Ageing SignsCognitive Decline+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 3, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions